Duration of Norethindrone Therapy to Induce Withdrawal Bleed
Norethindrone should be administered for 5 to 10 days to induce a withdrawal bleed, with the option to start with a shorter 5-day course and repeat if no bleeding occurs. 1
Recommended Dosing Regimens
The Endocrine Society guideline provides three equivalent options for progestin challenge testing 1:
- Norethindrone acetate: 5 mg daily for 5 to 10 days 1
- Medroxyprogesterone acetate: 5 to 10 mg daily for 5 to 10 days 1
- Micronized progesterone: 200 to 300 mg daily for 10 days 1
Practical Implementation Strategy
Start with a 5-day course as the initial approach. 1 This shorter duration is better tolerated by patients who may experience progestin-related side effects. 1 If no withdrawal bleed occurs within a few weeks after the 5-day course, repeat the treatment before proceeding to further evaluation. 1
The 10-day course represents the upper end of the recommended range and may be reserved for situations where a more robust endometrial response is desired or when the initial 5-day course fails to produce bleeding. 1
Expected Timing of Withdrawal Bleed
After norethindrone acetate cessation, withdrawal bleeding typically begins within 2 to 3 days (mean 2.9 ± 0.7 days in one study). 2 This rapid onset allows for timely assessment of endometrial estrogen exposure and outflow tract patency.
Clinical Interpretation of Results
Absence of withdrawal bleeding after a progestin course indicates either outflow tract obstruction or insufficient endometrial estrogen exposure. 1 This finding has important diagnostic implications:
- Low estrogen state: The endometrium has not been adequately primed by estrogen, suggesting hypothalamic amenorrhea, ovarian insufficiency, or severe hypoestrogenism 1
- Anatomic obstruction: Müllerian tract abnormalities or Asherman syndrome preventing blood egress 1
Follow-up pelvic ultrasound is necessary when no withdrawal bleed occurs to assess endometrial thickness and Müllerian tract integrity, with MRI confirmation if needed. 1
Common Pitfalls to Avoid
Do not use norethindrone doses intended for contraception (0.35 mg daily) when attempting to induce withdrawal bleeding; this dose is insufficient for endometrial transformation and withdrawal. 3, 4
Do not wait longer than a few weeks after failed withdrawal to repeat the challenge or pursue imaging. 1 Delayed evaluation postpones diagnosis of potentially serious conditions like outflow obstruction.
Do not assume treatment failure after only 5 days without allowing adequate time for withdrawal bleeding to occur. 1 Wait at least 2 weeks post-treatment before concluding the challenge was negative.
Be aware that norethindrone acetate at therapeutic doses (5-10 mg daily) partially converts to ethinylestradiol, which may cause heavier withdrawal bleeding compared to other progestins and carries implications for women with migraine with aura or thrombotic risk factors. 5